No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Annual revenue · last 0 fiscal years
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
The latest delayed quote for Polyrizon Ltd. (PLRZ) stock was $9.67 as of Oct 6, 2026, 4:00 PM EDT, up 3.42% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +41.4%
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays.
Biotechnology · Ra'anana, TA
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$-0.79
vs Estimate
N/A
Revenue
$0.00
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1PLRZ | $10.83M | $9.67 | +3.42% | +41.36% | N/A | N/A | N/A |
| 2BIVI | $10.86M | $1.44 | +0.00% | -26.05% | -70.37% | -54.09% | vs PLRZ |
| 3CNSY | $10.94M | $1.59 | +1.92% | N/A | N/A | N/A | vs PLRZ |
| 4PLUR | $10.68M | $0.99 | -4.35% | -77.28% | -44.78% | -38.09% | vs PLRZ |
| 5GDTC | $11.00M | $0.93 | -7.94% | -49.59% | N/A | N/A | vs PLRZ |
| 6LSTA | $11.02M | $1.21 | -3.97% | -49.83% | -40.75% | -32.84% | vs PLRZ |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$9.67
High
N/A
